Angiographic Adverse Events, Creatine Kinase-MB Elevation, and Ischemic End Points Complicating Percutaneous Coronary Intervention (a REPLACE-2 Substudy)

This publication has 29 references indexed in Scilit:

• Angiographic adverse events during percutaneous coronary intervention fail to predict creatine kinase-MB elevation
  Catheterization and Cardiovascular Interventions, 2004
• Angiographic variables predict increased riskfor adverse ischemic events after coronarystenting with glycoprotein IIb/IIIa inhibition
  Journal of the American College of Cardiology, 2003
• Death Following Creatine Kinase-MB Elevation After Coronary Intervention
  Circulation, 2002
• Frequency and long-term impact of myonecrosis after coronary stenting
  Published by Oxford University Press (OUP) ,2002
• Minor Myocardial Damage and Prognosis
  Circulation, 2002
• Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction
  Journal of the American College of Cardiology, 2000
• Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices
  Catheterization and Cardiovascular Interventions, 1999
• Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: Insights from the coronary angioplasty versus excisional atherectomy trial (CAVEAT)
  Journal of the American College of Cardiology, 1995
• Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting
  The American Journal of Cardiology, 1994
• Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty
  Journal of the American College of Cardiology, 1991